|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0023413,
umls-concept:C0030705,
umls-concept:C0036525,
umls-concept:C0123931,
umls-concept:C0205390,
umls-concept:C0585332,
umls-concept:C0701185,
umls-concept:C0936116,
umls-concept:C1446539,
umls-concept:C1521750,
umls-concept:C1522484,
umls-concept:C1527249,
umls-concept:C1556094,
umls-concept:C2603343
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-12-23
|
|
pubmed:abstractText |
We aimed to evaluate the safety and efficacy of combination chemotherapy with biweekly irinotecan (CPT-11) plus oral tegafur/uracil (UFT) and leucovorin (LV) in patients with previously untreated metastatic colorectal adenocarcinoma in phase I/II setting.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1432-0843
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
63
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
501-7
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18461329-Adult,
pubmed-meshheading:18461329-Aged,
pubmed-meshheading:18461329-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18461329-Camptothecin,
pubmed-meshheading:18461329-Colorectal Neoplasms,
pubmed-meshheading:18461329-Female,
pubmed-meshheading:18461329-Humans,
pubmed-meshheading:18461329-Japan,
pubmed-meshheading:18461329-Leucovorin,
pubmed-meshheading:18461329-Male,
pubmed-meshheading:18461329-Middle Aged,
pubmed-meshheading:18461329-Neoplasm Metastasis,
pubmed-meshheading:18461329-Survival Analysis,
pubmed-meshheading:18461329-Tegafur,
pubmed-meshheading:18461329-Uracil
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients.
|
|
pubmed:affiliation |
Department of Surgery, School of Medicine, Keio University, Shinanomachi, Shinjyuku-ku, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
